Status:
COMPLETED
Discussing COVID-19 Vaccines in Private Facebook Groups
Lead Sponsor:
George Washington University
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the prolif...
Eligibility Criteria
Inclusion
- reside in the U.S.
- unvaccinated from COVID-19
- Use Facebook regularly (at least 1/day)
Exclusion
- age \<18 years
- do not reside in the U.S.
- vaccinated from COVID-19
- do not use Facebook regularly (at least 1/day)
Key Trial Info
Start Date :
January 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2022
Estimated Enrollment :
508 Patients enrolled
Trial Details
Trial ID
NCT05422898
Start Date
January 17 2022
End Date
April 4 2022
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
George Washington University
Washington D.C., District of Columbia, United States, 20052